Skip to content

Postoperative Pain and Tenesmus After Doppler-Guided Hemorrhoidal Artery Ligation With or Without Mucopexy

Comparison of Postoperative Pain and Tenesmus Between Doppler-Guided Hemorrhoidal Artery Ligation Alone and Doppler-Guided Hemorrhoidal Artery Ligation Combined With Mucopexy in Patients With Hemorrhoidal Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07710053
Enrollment
150
Registered
2026-07-17
Start date
2026-10-01
Completion date
2027-07-01
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Hemorrhoids, Postoperative Pain

Brief summary

Hemorrhoidal disease is one of the most common anorectal disorders affecting adults worldwide. Doppler-guided hemorrhoidal artery ligation (HAL) is a minimally invasive surgical technique that has gained popularity because of its lower postoperative pain and faster recovery compared with conventional hemorrhoidectomy. In selected patients, HAL may be combined with mucopexy to address prolapsing hemorrhoidal tissue. The aim of this prospective study is to compare postoperative pain and tenesmus between patients undergoing Doppler-guided hemorrhoidal artery ligation alone and those undergoing Doppler-guided hemorrhoidal artery ligation combined with mucopexy. Patients diagnosed with hemorrhoidal disease and scheduled for surgical treatment at the General Surgery Department of Tokat Gaziosmanpaşa University Hospital will be enrolled after obtaining ethics committee approval and informed consent. Eligible participants will be adults aged 18 years and older without any concomitant anal canal disease. Participants will be allocated into two groups according to the surgical technique performed: (1) Doppler-guided hemorrhoidal artery ligation alone and (2) Doppler-guided hemorrhoidal artery ligation combined with mucopexy. Postoperative pain will be assessed using a pain scale at the 8th postoperative hour and at the 1st postoperative month. Tenesmus symptoms will be evaluated and recorded at the 2nd postoperative month. The primary outcomes will be postoperative pain scores and the presence of tenesmus. Comparative statistical analyses will be performed between the two groups.

Interventions

PROCEDUREHAL + Mucopexy

Doppler-guided hemorrhoidal artery ligation will be performed using a Doppler-equipped proctoscope to identify and ligate hemorrhoidal arteries. Following arterial ligation, mucopexy will be performed to lift and secure the prolapsing hemorrhoidal mucosa.

PROCEDUREHAL Alone

Participants will undergo Doppler-guided hemorrhoidal artery ligation alone for the treatment of hemorrhoidal disease. Hemorrhoidal arteries will be identified using Doppler guidance and ligated without additional mucopexy.

Sponsors

Ali Genc
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Diagnosis of hemorrhoidal disease requiring surgical treatment * Ability to provide written informed consent * Willingness to participate in the study.

Exclusion criteria

* Age below 18 years * Presence of other anal canal diseases (anal fissure, anal fistula, anorectal malignancy, inflammatory bowel disease involving the anorectal region, etc.) * Previous anorectal surgery that may affect study outcomes * Inability or unwillingness to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain Score (VAS)Postoperative Hour 8Assessment of pain severity using the Visual Analog Scale (VAS) at the 8th postoperative hour.

Secondary

MeasureTime frameDescription
Postoperative Pain Score1 month after surgeryAssessment of pain severity using the Visual Analog Scale (VAS) at the 1st postoperative month.

Contacts

CONTACTAli Genç, Assistant professor
aligenc0860@outlook.com+90-3562129500
CONTACTMuzaffer Katar, Associate Professor
Muzaffer.katar@gop.edu.tr0 (356) 212 95 00 - 7515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026